GENCURIX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 07 Dec 2023)
What this means for you
Registered since 28 Mar 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 28 Mar 2027, and its filing window is open now).
Record
- Serial number
- 86930543
- Registration number
- 5172887
- Mark type
- Word mark
- Filed
- 07 Mar 2016
- Published for opposition
- 16 Aug 2016
- Registered
- 28 Mar 2017
- Next maintenance filing
- §8 & §9 renewal, due by 28 Mar 2027 (grace period to 28 Sept 2027)
- Attorney of record
- Corey K. Cho
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of DNA chips; Biotechnology research; Biological research; Research and development in the field of chemistry; Chemistry consultation; Chemical research and analysis; Biological research services; Biotechnology research on cancer; Product research in the field of medicine; Medical research
Owner
- GENCURIX Inc., Seoul, KR
- GENCURIX Inc., Seoul, KR
- GENCURIX Inc., Seoul, KR
Prosecution history
- 28 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Dec 2023 — NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
- 07 Dec 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Apr 2023 — REQUEST FOR SECT 7 TOTAL SURRENDER FILED
- 07 Dec 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Apr 2023 — TEAS SECTION 7 SURRENDER RECEIVED
- 14 Feb 2023 — TEAS SECTION 8 & 15 RECEIVED
- 28 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Feb 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Feb 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
- 22 Feb 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Feb 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Feb 2017 — EXAMINER'S AMENDMENT ENTERED